Effect of tacrine on intracellular calcium in cholinergic SN56 neuronal cells

Brain Research

Volumn 769, Issue 2, 1997, Pages 219-224

  Doležal, Vladimír ^a   Lisá, Věra ^a   Tuček, Stanislav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Acetylcholinesterase; Calcium channels; Calcium imaging; Intracellular calcium; Neurons in culture; SN56 neuronal cell line; Tacrine

Indexed keywords

CALCIUM CHANNEL; TACRINE;

ARTICLE; CALCIUM CELL LEVEL; CHOLINERGIC NERVE; DEPOLARIZATION; DRUG EFFECT; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; NERVE POTENTIAL; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARBACHOL; CELL FUSION; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTRACELLULAR MEMBRANES; MICE; MUSCARINIC AGONISTS; NEURONS; NICOTINIC AGONISTS; POTASSIUM CHLORIDE; TACRINE; TUMOR CELLS, CULTURED;

EID: 0342602025     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00711-7     Document Type: Article

References (46)

1. Bajgar J., Fusek J., Patočka J., Hrdina V. In vivo kinetics of blood cholinesterase inhibition by 9-amino-1,2,3,4-tetrahydroacridine, its 7-methoxy derivative and physostigmine in rats. Physiol. Bohemoslov. 28:1979;31-34.
2. Berse B., Blusztajn J.K. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J. Biol. Chem. 270:1995;22101-22104.
3. Blusztajn J.K., Venturini A., Jackson D.A., Lee H.J., Wainer B.H. Acetylcholine synthesis and release is enhanced by dibutyryl cyclic AMP in a neuronal cell line derived from mouse septum. J. Neurosci. 12:1992;793-799.
4. Buyukuysal R.L., Wurtman R.J. Tetrahydroaminoacridine but not 4-aminopyridine inhibits high-affinity choline uptake in striatal and hippocampal synaptosomes. Brain Res. 482:1989;371-375.
5. Byrne E., Arie T. Tetrahydroaminoacridine and Alzheimer's disease. For the few, but we don't know which few. Br. Med. J. 308:1994;868-869.
6. Doležal V., Tuček S. Failure of the calcium channel activator, Bay K 8644, to increase the release of acetylcholine from nerve terminals in brain and diaphragm. Br. J. Pharmacol. 91:1987;475-479.
7. Doležal V., Tuček S. Positive and negative effects of tacrine (tetrahydroaminoacridine) and methoxytacrine on the metabolism of acetylcholine in brain cortical prisms incubated under 'resting' conditions. J. Neurochem. 56:1991;1207-1215.
8. Doležal V., Tuček S. Investigation of the mechanism of the effect of tacrine (tetrahydroaminoacridine) on the metabolism of acetylcholine and choline in brain cortical prisms. J. Neural. Transm. Park. Dis. Dement. Sect. 4:1992;303-318.
9. 2-adrenoceptors: insights into the role of N- and L-type calcium channels. Brain Res. 721:1996;101-110.
10. 5 muscarinic acetylcholine receptor subtypes on intracellular calcium and on the incorporation of choline into membrane lipids in genetically modified Chinese hamster ovary cell lines. Brain Res. Bull. 42:1977;71-78.
11. + current. Eur. J. Pharmacol. 141:1987;153-157.
12. Drukarch B., Leysen J.E., Stoof J.C. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Life Sci. 42:1988;1011-1017.
13. Ellman G., Courtney K.D., Andrews V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
14. Flynn D.D., Mash D.C. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J. Pharmacol. Exp. Ther. 250:1989;573-581.
15. + channel by tacrine: interactions with muscarinic and adenosine receptors. Eur. J. Pharmacol. 154:1988;59-65.
16. S. Gauthier, H. Masson, L. Gauthier, R. Bouchard, B. Collier, Y. Bacher, R. Bailey, R. Becker, H. Bergman, R. Charbonneau, D. Dastoor, D. Gayton, J. Kennedy, C. Kissel, M. Krieger, S. Kushnir, A. Lamontagne, M. St. Martin, J. Morin, N.P.V. Nair, L. Neirinck, J. Ratner, S. Suissa, Y. Tesfaye, S. Vida, Tetrahydroaminoacridine and lecithin in Alzheimer's disease, in: E. Giacobini, R. Becker (Eds.), Current Research in Alzheimer Therapy, Taylor and Francis, New York, 1988, pp. 237-245.
17. Gibson G.E., Manger T. Changes in cytosolic free calcium with 1,2,3,4-tetrahydro-5-aminoacridine, 4-aminopyridine and 3,4-diaminopyridine. Biochem. Pharmacol. 37:1988;4191-4196.
18. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
19. Hammond D.N., Lee H.J., Tonsgard J.H., Wainer B.H. Development and characterization of clonal cell lines derived from septal cholinergic neurons. Brain Res. 512:1990;190-200.
20. Heilbronn E. Inhibition of cholinesterases by tetrahydroaminoacridine. Acta Chem. Scand. 15:1961;1386-1390.
21. Hershkowitz N., Rogawski M.A. Tetrahydroaminoacridine block of N-methyl-D-aspartate-activated cation channels in cultured hippocampal neurons. Mol. Pharmacol. 39:1991;592-598.
22. Jarlebark L., Heilbronn E. Tetrahydroaminoacridine and related compounds interfere with fura-2 and indo-1. Eur. J. Pharmacol. 225:1992;75-77.
23. Kelly K.M., Gross R.A., MacDonald R.L. Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons. Neurosci. Lett. 132:1991;247-250.
24. Lee H.J., Hammond D.N., Large T.H., Wainer B.H. Immortalized young adult neurons from the septal region: generation and characterization. Dev. Brain Res. 52:1990;219-228.
25. Lindmar R., Löffelholz K. The effect of tacrine on acetylcholine overflow in the heart. Eur. J. Pharmacol. 190:1990;251-254.
26. Loiacono R.E., Mitchelson F.J. Effect of nicotine and tacrine on acetylcholine release from rat cerebral cortical slices. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1990;31-35.
27. Marquis J.K. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine. Biochem. Pharmacol. 40:1990;1071-1076.
28. Marsh S.J., Hubbard A., Brown D.A. Some actions of 9-amino-1,2,3,4-tetrahydroacridine (THA) on cholinergic transmission and membrane currents in rat sympathetic ganglia. Eur. J. Neurosci. 2:1990;1127-1134.
29. Musílková J., Tuček S. The binding of cholinesterase inhibitors tacrine (tetrahydroaminoacridine) and 7-methoxytacrine to muscarinic acetylcholine receptors in rat brain in the presence of eserine. Neurosci. Lett. 125:1991;113-116.
30. Nielsen J.A., Mena E.E., Williams I.H., Nocerini M.R., Liston D. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol. 173:1989;53-56.
31. Nilsson L., Adem A., Hardy J., Winblad B., Nordberg A. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? J. Neural. Transm. 70:1987;357-368.
32. Nilsson-Hakansson L., Lai Z., Nordberg A. Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain. Eur. J. Pharmacol. 186:1990;301-305.
33. Osterrieder W. 9-Amino-1,2,3,4-tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels. Br. J. Pharmacol. 92:1987;521-525.
34. Pearce B.D., Potter L.T. Effects of tetrahydroaminoacridine on M1 and M2 muscarine receptors. Neurosci. Lett. 88:1988;281-285.
35. Pedersen W.A., Berse B., Schuler U., Wainer B.H., Blusztajn J.K. All-trans- and 9-cis-retinoic acid enhance the cholinergic properties of a murine septal cell line: evidence that the effects are mediated by activation of retinoic acid receptor-alpha. J. Neurochem. 65:1995;50-58.
36. Perney T.M., Hirning L.D., Leeman S.E., Miller R.J. Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc. Natl. Acad. Sci. USA. 90:1986;6656-6659.
37. Perry E.K., Smith C.J., Court J.A., Bonham J.R., Rodway M., Atack J.R. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro. Neurosci. Lett. 91:1988;211-216.
38. Potter L.T., Ferrendelli C.A., Hanchett H.E., Hollifield M.A., Lorenzi M.V. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors. Mol. Pharmacol. 35:1989;652-660.
39. Rogawski M.A. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142:1987;169-172.
40. Stevens D.R., Cotman C.W. Excitatory actions of tetrahydro-9-aminoacridine (THA) on hippocampal pyramidal neurons. Neurosci. Lett. 79:1987;301-305.
41. Summers W.K., Majovski L.V., Marsh G.M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315:1986;1241-1245.
42. 2 receptors. Brain Res. 726:1996;207-212.
43. Tuček S., Doležal V. Negative effects of tacrine (tetrahydroaminoacridine) and methoxytacrine on the metabolism of acetylcholine in brain slices incubated under conditions stimulating neurotransmitter release. J. Neurochem. 56:1991;1216-1221.
44. 2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. USA. 90:1993;9518-9522.
45. Wagstaff A.J., McTavish D. Tacrine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in Alzheimer's disease. Drugs Aging. 4:1994;510-540.
46. Xiao W.B., Nordberg A., Zhang X. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. J. Pharmacol. Exp. Ther. 265:1993;759-764.